Comprehensive Genomic Profiling of Small-Cell Lung Cancer Reveals Frequent Potentially Targetable Alterations
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311512 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dániel Schmalz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Omics, János Szentágothai Research Center, University of Pécs, Ifjúság Street 20, 7624 Pécs, Hungary. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche.
Abstract (Originalsprache)
Small-cell lung carcinoma (SCLC) remains one of the most aggressive lung cancers and continues to pose a major challenge for precision oncology. Despite its morphological uniformity, SCLC exhibits marked molecular heterogeneity with recurrent, potentially targetable genomic alterations. Comprehensive profiling is often hindered by limited tissue availability and the need for rapid therapeutic intervention. We performed genomic profiling of 55 primary and metastatic SCLC samples using a 324-gene hybrid-capture next-generation sequencing panel. Consistent with prior reports, nearly all tumors exhibited biallelic TP53 and RB1 inactivation. Recurrent alterations involved the PI3K/Akt/mTOR pathway (62%), chromatin regulators (42%), and NOTCH signaling genes (15%). PTEN mutations were enriched in brain metastases. Frequent copy-number gains affected SOX2, NKX2-1, MYC-family genes, and CCNE1. Two novel recurrent amplifications of potential clinical significance were identified: TYRO3 (33%) and SDHA (13%). TYRO3, a TAM family receptor tyrosine kinase, and SDHA, a mitochondrial enzyme involved in succinate metabolism, may contribute to tumor progression and represent emerging therapeutic vulnerabilities. These findings underscore the genomic diversity of SCLC and highlight the potential utility of broad next-generation sequencing in uncovering new molecular targets for precision therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Omics, János Szentágothai Research Center, University of Pécs, Ifjúság Street 20, 7624 Pécs, Hungary.
- Department of Pathology, Clinical Centre, University of Pécs, Szigeti Street 12, 7624 Pécs, Hungary.
- 1st Department of Internal Medicine, Clinical Centre, University of Pécs, Ifjúság Street 13, 7624 Pécs, Hungary.
- Department of Oncotherapy, Clinical Centre, University of Pécs, Édesanyák Street 17, 7624 Pécs, Hungary.
ORCID-Profile: Péter Urbán, István Ruzsics, Béla Kajtár
Förderung
- F. Hoffmann-La Roche
Zitieren
APA
Schmalz, D., Krabóth, Z., Czoma, V., Urbán, P., Gyenesei, A., Ruzsics, I., Sárosi, V., Boronkai, Á., Papp, E., & Kajtár, B. (2025). Comprehensive Genomic Profiling of Small-Cell Lung Cancer Reveals Frequent Potentially Targetable Alterations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311512
Vancouver
Schmalz D, Krabóth Z, Czoma V, Urbán P, Gyenesei A, Ruzsics I, et al. Comprehensive Genomic Profiling of Small-Cell Lung Cancer Reveals Frequent Potentially Targetable Alterations. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311512
BibTeX
@article{Schmalz2025,
author = {Schmalz, Dániel and Krabóth, Zoltán and Czoma, Veronika and Urbán, Péter and Gyenesei, Attila and Ruzsics, István and Sárosi, Veronika and Boronkai, Árpád and Papp, Emőke and Kajtár, Béla},
title = {Comprehensive Genomic Profiling of Small-Cell Lung Cancer Reveals Frequent Potentially Targetable Alterations},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311512}
}
EUVIMED